XON - Intrexon Corp - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - XON (1356090)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
58 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-01-31
PGENKirk Randal JExec COB, 10%P - Purchase$5.86+5,972,69681,523,936+8%+$34,999,999
D
2020-01-06
XONBostick ThomasCOOS - Sale+OE$5.83-6,53374,280-8%-$38,083
D
2020-01-06
XONLehr Donald P.GCS - Sale+OE$5.83-7,15593,991-7%-$41,708
D
2020-01-06
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$5.83-6,53380,948-7%-$38,083
D
2020-01-06
XONReed Thomas D.Chief Science OfficerS - Sale+OE$5.83-5,416255,873-2%-$31,571
D
2020-01-06
XONSabzevari HelenPres, CEOS - Sale+OE$5.83-6,73298,002-6%-$39,243
D
2020-01-06
XONSterling Rick L.CFOS - Sale+OE$5.83-6,533143,032-4%-$38,082
D
2020-01-03
XONSterling Rick L.CFOS - Sale+OE$5.77-3,564130,625-3%-$20,564
D
2020-01-03
XONSabzevari HelenPres, CEOS - Sale+OE$5.77-3,88687,067-4%-$22,421
D
2020-01-03
XONReed Thomas D.Chief Science OfficerS - Sale+OE$5.77-2,986242,349-1%-$17,229
D
2020-01-03
XONBostick ThomasCOOS - Sale+OE$5.77-3,56461,873-5%-$20,564
D
2020-01-03
XONLehr Donald P.GCS - Sale+OE$5.77-3,88682,206-5%-$22,422
D
2020-01-03
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$5.77-3,56468,541-5%-$20,564
D
2020-01-02
XONSterling Rick L.CFOS - Sale+OE$5.60-4,366124,423-3%-$24,450
D
2020-01-02
XONSabzevari HelenPres, CEOS - Sale+OE$5.60-4,83081,187-6%-$27,048
D
2020-01-02
XONReed Thomas D.Chief Science OfficerS - Sale+OE$5.60-3,533235,569-1%-$19,785
D
2020-01-02
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$5.60-4,36662,339-7%-$24,450
D
2020-01-02
XONLehr Donald P.GCS - Sale+OE$5.60-4,83076,326-6%-$27,048
D
2020-01-02
XONBostick ThomasCOOS - Sale+OE$5.60-4,36655,671-7%-$24,450
D
2019-10-01
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$5.50-4,52152,365-8%-$24,847
D
2019-10-01
XONReed Thomas D.Chief Science OfficerS - Sale+OE$5.50-3,658224,762-2%-$20,104
D
2019-10-01
XONSterling Rick L.CFOS - Sale+OE$5.50-4,521114,449-4%-$24,847
D
2019-10-01
XONSabzevari HelenPres, Precigen, Inc.S - Sale+OE$5.50-5,00571,677-7%-$27,507
D
2019-10-01
XONBostick ThomasCOOS - Sale+OE$5.50-4,52145,697-9%-$24,847
D
2019-10-01
XONLehr Donald P.GCS - Sale+OE$5.50-5,00166,816-7%-$27,485
D
2019-07-18
XONSabzevari HelenPres, Precigen, Inc.S - Sale+OE$7.47-8,48462,341-12%-$63,377
D
2019-07-01
XONWalsh Robert F. IIISVP, Energy, Fine Chem.S - Sale+OE$7.76-5,00728,816-15%-$38,854
D
2019-07-01
XONSterling Rick L.CFOS - Sale+OE$7.76-4,359104,629-4%-$33,826
D
2019-07-01
XONSabzevari HelenPres, Precigen, Inc.S - Sale+OE$7.76-4,82245,825-10%-$37,419
D
2019-07-01
XONReed Thomas D.Chief Science OfficerS - Sale+OE$7.76-3,527214,079-2%-$27,370
D
2019-07-01
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$7.76-4,35942,545-9%-$33,826
D
2019-07-01
XONLehr Donald P.GCS - Sale+OE$7.76-4,82257,476-8%-$37,419
D
2019-07-01
XONBostick ThomasCOOS - Sale+OE$7.76-4,35935,877-11%-$33,826
M
2019-06-06
XONKirk Randal JCEO, 10%P - Purchase$5.24+322,17950,397,399+1%+$1,689,443
M
2019-06-06
XONKirk Randal JCEO, 10%P - Purchase$5.24+483,26823,980,893+2%+$2,534,162
M
2019-05-31
XONKirk Randal JCEO, 10%P - Purchase$4.91+135,54847,799,1900%+$665,516
M
2019-05-31
XONKirk Randal JCEO, 10%P - Purchase$4.91+203,32125,773,655+1%+$998,269
M
2019-05-29
XONKirk Randal JCEO, 10%P - Purchase$4.75+330,18049,754,783+1%+$1,567,799
M
2019-05-29
XONKirk Randal JCEO, 10%P - Purchase$4.75+495,27123,250,021+2%+$2,351,703
M
2019-05-22
XONKirk Randal JCEO, 10%P - Purchase$4.69+273,36749,424,603+1%+$1,280,804
M
2019-05-22
XONKirk Randal JCEO, 10%P - Purchase$4.69+410,05022,754,750+2%+$1,921,203
M
2019-05-17
XONKirk Randal JCEO, 10%P - Purchase$4.65+422,42349,151,236+1%+$1,966,075
M
2019-05-17
XONKirk Randal JCEO, 10%P - Purchase$4.65+633,63122,344,700+3%+$2,949,096
M
2019-05-13
XONKirk Randal JCEO, 10%P - Purchase$4.40+838,48248,728,813+2%+$3,688,026
M
2019-05-13
XONKirk Randal JCEO, 10%P - Purchase$4.40+1,257,72721,711,069+6%+$5,532,056
M
2019-03-04
XONReed Thomas D.Chief Science OfficerS - Sale$4.19-227,800203,265-53%-$954,408
D
2019-01-03
XONLehr Donald P.GCS - Sale+OE$7.07-3,83234,183-10%-$27,094
D
2019-01-03
XONPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$7.07-3,51418,789-16%-$24,846
D
2019-01-03
XONReed Thomas D.Chief Science OfficerS - Sale+OE$7.07-2,94479,537-4%-$20,816
D
2019-01-03
XONSabzevari HelenPres, Precigen, Inc.S - Sale+OE$7.07-3,83222,532-15%-$27,094
D
2019-01-03
XONSterling Rick L.CFOS - Sale+OE$7.07-3,51480,873-4%-$24,846
D
2019-01-03
XONWalsh Robert F. IIISVP, Energy, Fine Chem.S - Sale+OE$7.07-4,0585,708-42%-$28,692
D
2019-01-04
XONLiffman Joel DSVP, FinanceS - Sale+OE$7.03-3,72585,541-4%-$26,187
D
2019-01-03
XONNimrodi NirChief Business OfficerS - Sale+OE$7.07-4,05813,077-24%-$28,692
2018-12-31
XONReed Thomas D.Chief Science OfficerS - Sale$6.36-30,00072,715-29%-$190,671
2018-10-15
XONLiffman Joel DSVP, FinanceS - Sale$14.59-79,00079,500-50%-$1,152,808
D
2018-07-18
XONSabzevari HelenPres, Precigen, Inc.S - Sale+OE$14.54-8,40216,598-34%-$122,165
2018-07-03
XONKirk Randal JCEO, 10%P - Purchase$13.37+7,479,43166,789,237+13%+$99,999,992
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top